Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Atlantica Reports Third Quarter 2024 Financial Results
-
Natural Gas Services Group, Inc. Reports Third Quarter 2024 Financial and Operating Results; Increases FY 2024 Adjusted EBITDA Guidance
-
OMNIQ Reports $18.5 Million Revenue in the Third Quarter 2024
-
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
-
Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
-
Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Firsthand Technology Value Fund Announces Third Quarter Financial Results, NAV of $0.22 Per Share
-
Fluent Announces Third Quarter 2024 Financial Results; Strategic Pivot Accelerates with Growth of Commerce Media Solutions
-
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
-
Pineapple Financial, Inc. Announces Closing of $1.0 Million Registered Direct Offering at $0.60 per share
-
Fusion Fuel Issues Damages Claim Against Hydrogenial S.A. for Failure to Fund $33.5 Million Subscription Agreement; Announces Insolvency of Portuguese Subsidiary
-
Dragonfly Energy Reports Third Quarter 2024 Financial and Operational Results
-
ESCO Reports Fourth Quarter and Fiscal 2024 Results
-
TFF Pharmaceuticals Announces It Will Wind Down Operations
-
CEA Industries Inc. Reports Third Quarter 2024 Results
-
California Bank of Commerce Names Jerry Legg Director of Public Sector Banking
-
FRO – Notice of Annual General Meeting 2024
-
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
BEN Reports Third Quarter 2024 Financial Results
-
Red Cat to Host Town Hall Meeting for Investors, Analysts and Members of the Media
-
Panbela Provides Business Update and Reports Q3 2024 Financial Results
-
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
Fundamental Global Inc. Reports Third Quarter 2024 Financial Results
-
Motorsport Games Reports Third Quarter 2024 Financial Results
-
BC First Nations Justice Council Receives Funding from Public Safety Canada for Innovative Pre-Charge Diversion Program in Lheidli T’enneh Territory (Prince George, BC)
-
Avista Corp. Board Declares Common Stock Dividend
-
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
-
Rocky Mountain Chocolate Factory Announces the Opening of Two New Store Locations and Kiosk
-
TILT Holdings Reports Third Quarter 2024 Results and Announces Strategic Review of its Plant-Touching Business
-
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
-
Thunder Power Reports Unaudited Third Quarter 2024 Financial Results
-
Canadian North Resources Inc. Announces Appointment Of Henderson Tse To The Board Of Directors
-
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
iPower Reports Fiscal First Quarter 2025 Results
-
Alumis Presents Data Highlighting ESK-001’s Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024
-
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
-
T2 Biosystems Announces Third Quarter 2024 Financial Results
-
Aqua Metals Announces Progress on Operational Achievements and Ongoing Commercial Development, Reports Third Quarter 2024 Results
-
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
-
Rekor Systems Reports Third Quarter 2024 Financial Results
-
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
-
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
-
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
-
Expion360 Reports Third Quarter 2024 Financial Results
-
Lesaka gets green light to launch Employee Share Ownership Plan
-
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
-
RYVYL Reports Q3 2024 Results
-
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
-
Airship AI Reports Third Quarter 2024 Financial Results

